查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495913

产后出血（PPH）治疗设备的全球市场

Postpartum Hemorrhage (PPH) Treatment Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 207 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球产后出血 (PPH) 治疗设备市场预计将达到 11 亿美元

预计到 2023 年，全球产后出血 (PPH) 治疗设备市场规模将达到 7.893 亿美元，预计在 2023 年至 2030 年分析期间将以 4% 的复合年增长率增长，到 2030 年将达到 11 亿美元。子宫球囊填塞是本报告分析的细分市场之一，预计复合年增长率为 3.7%，到分析期结束时将达到 5.059 亿美元。预计未来八年非气动抗震服饰 (NASG) 领域的复合年增长率为 4%。

美国市场预计将达2.786亿美元，中国预计复合年增长率为5.4%

预计 2023 年美国产后出血 (PPH) 治疗设备市场规模将达 2.786 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.468亿美元，2023年至2030年的分析期间复合年增长率为5.4%。其他值得注意的区域市场包括日本和加拿大，预计 2023 年至 2030 年将分别成长 2.8% 和 4%。在欧洲，德国的复合年增长率预计约为 3.3%。以澳洲、印度和韩国等国家为首的亚太市场预计到2030年将达到9,030万美元。

2024 年推出令人兴奋的新报告功能

完全访问影响者参与统计数据

免费存取数位檔案和「MarketGlass」研究平台。我们独特的 MarketGlass 平台使我们能够集体协作地释放世界各地专家的创造力和市场知识。我们的尖端工具提供世界一流的市场可视性，同时保护市场参与企业的隐私和身分。报告中的数字、统计数据和市场描述是基于该领域专家和影响者共用的全面见解。

使用即时资料模拟器工具和客製化报告功能参与互动式调查。

客户全面连结同侪协作互动平台，实现企业间智慧交流

1 年免费报告更新

竞争覆盖范围，包括主要参与者的全球市场占有率

多个地区参与者的市场影响分析（强/活跃/利基/次要）

访问专家/影响者访谈、播客、新闻稿和活动主题演讲的 YouTube 视频

2024 年世界经济有何预期

货币紧缩和相关利率上升导致的地缘政治和经济不稳定将在 2024 年造成动盪的局面。一些因素将继续给復苏之路带来压力，包括中东的敌对行动和日益频繁的气候灾害。儘管存在风险，但一些积极因素正在显现，包括通膨放缓的征兆更加明显、对顽固通膨的担忧有所缓解、供应链正常化以及儘管能源成本出现波动但价格仍有所回落。印度和美国等二十一国集团国家的选举可能会影响资本流动和投资策略。儘管印度作为全球投资目的地的地位日益突出，但在充满活力的人才和资本生态系统的推动下，美国科技公司将继续占据主导地位。儘管该国经济放缓，但由于国内经济富有弹性和有利的法规环境，高科技机会（尤其是硅谷）仍然对寻求高成长潜力的投资者俱有吸引力。欧洲持续应对紧缩的货币政策和景气衰退风险，但英国的前景最严峻，2024 年景气衰退的风险最高。中国仍然是通用凭证，其成长预计将受到政府支出和消费者支出改善的支持。动盪的环境可能为投资者和公司带来机会和挑战。将波动性视为成长的催化剂，并以敏捷性和策略远见来制定投资决策，对于生存仍然至关重要。

受访企业范例（共26家）

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 其他拉丁美洲
  • 中东
  • 非洲

第四章 比赛

简介目录
Product Code: MCP15984

Global Postpartum Hemorrhage (PPH) Treatment Devices Market to Reach $1.1 Billion by 2030

The global market for Postpartum Hemorrhage (PPH) Treatment Devices estimated at US$789.3 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4% over the analysis period 2023-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$505.9 Million by the end of the analysis period. Growth in the Non-Pneumatic Anti-shock Garment (NASG) segment is estimated at 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $278.6 Million, While China is Forecast to Grow at 5.4% CAGR

The Postpartum Hemorrhage (PPH) Treatment Devices market in the U.S. is estimated at US$278.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$146.8 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$90.3 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 26 Featured) -

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Postpartum Hemorrhage - The Leading Cause of Maternal Death Globally
    • PPH: Management using PPH Treatment Devices
    • EXHIBIT 1: Global Postpartum Hemorrhage (PPH) Treatment Devices Market by Geographic Region: Annual Sales in Million Units for the Years 2023 through 2030
    • EXHIBIT 2: Global Postpartum Hemorrhage (PPH) Treatment Devices Market by Product Segment: Annual Sales in Thousand Units for the Years 2022 through 2030
    • Economic Frontiers: Trends, Trials & Transformations
    • EXHIBIT 3: In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 4: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • EXHIBIT 5: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • Competitive Landscape
    • EXHIBIT 6: Postpartum Hemorrhage (PPH) Treatment Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 26 Players Worldwide in 2024 (E)
    • Global Market Prospects and Outlook
    • Global Postpartum Hemorrhage Devices Market Sets Eyes on Pulsating Growth Ahead
    • Uterine Balloon Tamponades Lead the Global PPH Treatment Devices Market
    • US and Europe Account for Major Share of the Market
    • Developing and Developed Countries Investing More in Healthcare Industry
    • Restraining Factors for Market Growth
    • Recent Market Activity
    • Influencer/Product/Technology Insights
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Robust Scope for Device Innovations to Shoulder Burden of Mortality Reduction Goals
    • EXHIBIT 7: PPH Device R&D Pipeline: Breakdown of PPH Devices by Development Status
    • EXHIBIT 8: Current PPH Devices Ecosystem by Archetype & Clinical Use Status
    • Existing & Promising Postpartum Hemorrhage Devices
    • Balloons Command while New Options Emerge
    • Uterine balloon Tamponade PPH Devices by Archetype & Clinical Use Status
    • Widespread Use of Repurposed & Improvised PPH Devices
    • The Way Forward
    • Novel Techniques for Accurate, Timely Detection & Efficient Management of PPH
    • Timely Hemorrhage Detection
    • Fixed-Ratio Transfusion
    • Viscoelastic Hemostatic Assays
    • Approaches to Reduce Disparate Outcomes
    • Obstetricians Develop Novel Intrauterine PPH Device to Control Postpartum Bleeding
    • Increase in Birth Rate Offers Opportunities for Postpartum Hemorrhage Market
    • EXHIBIT 9: Global New Births (in Millions) per Annum by Geographic Region
    • Birth Statistics Across the World
    • Rise in Pregnancy Complications Drives Market Growth
    • Prevalence of Anaemia in Pregnant Women Bolsters Demand
    • The Millennials Reaching Child-Bearing Age Drive Healthy Market Growth
    • EXHIBIT 10: Global Millennial Population by Region (2023): Percentage Breakdown of Number of Millennials for North America, Europe, China & Japan, Latin America and Rest of World
    • EXHIBIT 11: Millennial Population as a Percentage (%) of Total Population in Developing Countries: 2023
    • Rising Working Women Population Increases the Risk of PPH
    • EXHIBIT 12: Top 10 Countries Worldwide with the Highest Proportion of Working Women in the Nation's Women Population
    • Rising Obesity Incidence Spurs the Demand for PPH Treatment Devices
    • EXHIBIT 13: Obesity Prevalence Rate (%) in Select Countries for the Years 2023 and 2030P
    • Non-Pneumatic Anti-Shock Garment Witnesses Increased Demand
    • Leading Players and Market Share
    • EXHIBIT 14: Global Non-Pneumatic Anti-Shock Garment (NASG) Market (2023): Market Share of Major Players
    • EXHIBIT 15: Reduction in Maternal Mortality Rates due to Obstetric Hemorrhage from the Use of NASG in Select Countries
    • Supply
    • Challenges and Issues
    • Uterotonics: The Lifeblood of the Bundle Approach to Manage Postpartum Hemorrhage
    • More Focus on Uterine Atony & Uterotonics
    • Uterotonics Move Forward with New Advances to Prevent Postpartum Hemorrhage
    • Device Innovations to Control PPH to Drive Market Growth
    • PATH and Sinapi Biomedical Introduce Ellavi for Combating Postpartum Hemorrhage
    • PPH Butterfly
    • Intrauterine Vacuum Device Plays a Crucial Role in Controlling Postpartum Hemorrhage Safely and Quickly
    • Tools to Detect and Treat Postpartum Hemorrhage Minimize Maternal Deaths
    • New Wearable Optical Device for Timely Detection of Postpartum Hemorrhage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Uterine Balloon Tamponade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Uniject Prefilled Injection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Market Analytics
    • TABLE 14: USA Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • JAPAN
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • CHINA
    • TABLE 23: China Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • EUROPE
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Market Analytics
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • FRANCE
    • TABLE 32: France Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • GERMANY
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 41: UK Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Market Analytics
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • INDIA
    • TABLE 62: India Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 80: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • TABLE 83: Middle East Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Middle East Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Middle East 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • AFRICA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • Market Analytics
    • TABLE 86: Africa Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Africa Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Africa 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030

IV. COMPETITION